GlobalData on MSN

Life Bio receives FDA approval for ER-100 clinical trial

The Phase I trial will recruit participants who have been diagnosed with non-arteritic anterior ischaemic optic neuropathy ...

FDA approves drug to treat dogs with idiopathic epilepsy

The U.S. Food and Drug Administration (FDA) has approved a drug to control seizures in dogs with idiopathic epilepsy, a type ...
CURE

FDA Approves Larger Nelarabine Vial for Some Leukemias and Lymphomas

The FDA approved a larger nelarabine vial to improve dosing flexibility and simplify treatment for adult and pediatric ...
CURE

FDA Approves Darzalex Faspro-VRd For Newly Diagnosed, Transplant Ineligible Multiple Myeloma

The FDA approved Darzalex Faspro with Velcade, Revlimid and dexamethasone for newly diagnosed multiple myeloma ineligible for ...
MPR

Yuvezzi Approved as Once-Daily Combination Therapy for Presbyopia

Yuvezzi, a combination cholinergic agonist and alpha-adrenergic agonist, is now FDA-approved as a once-daily treatment for ...
Ophthalmology Times

FDA approves NDA labeling supplement allowing re-administration of iDose TR

The FDA approved re-administration of iDose TR for patients with healthy corneas, enhancing treatment flexibility for ...
KTVU FOX 2

FDA approves drug to treat dogs with lymphoma cancer

The U.S. Food and Drug Administration (FDA) has granted full approval of Laverdia, a drug to treat dogs with lymphoma, a type ...
WLKY

FDA to streamline approvals for generic biological drugs in latest move targeting health costs

The U.S. Food and Drug Administration will take steps to streamline the process to develop generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to ...